首页> 外国专利> METHOD FOR PRODUCING OR ENHANCING A T-CELL RESPONSE AGAINST A TARGET CELL USING A COMPLEX COMPRISING AN HLA CLASS I MOLECULE AND AN ATTACHING MEANS

METHOD FOR PRODUCING OR ENHANCING A T-CELL RESPONSE AGAINST A TARGET CELL USING A COMPLEX COMPRISING AN HLA CLASS I MOLECULE AND AN ATTACHING MEANS

机译:使用包含I类HLA分子和结合装置的复合物产生或增强针对靶细胞的T细胞反应的方法

摘要

A complex comprising an HLA class I molecule and attaching meansfor selectively attaching the HLA class I molecule to a target cell isdisclosed,and a method is provided for producing or enhancing an immunologicalresponse against a target cell, by attaching said complex to the target cell.Where the target cell is a diseased, foreign or malignant cell, this methodmaybe used to promote the lysis of the target cell by T cells in the immunesystem.Where the target cell is an antigen presenting cell, this method may be usedto promote the proliferation of specific T cell clones. The invention is ofpotential use in the prevention and treatment of malignant diseases includingcancer and leukaemia, infectious diseases including viral infections suchas HIV, bacterial infections including tuberculosis, and parasitic infectionsincluding malaria.
机译:包含HLA I类分子和附着手段的复合物用于将HLA I类分子选择性附着于靶细胞的方法是披露,提供了产生或增强免疫学的方法通过将所述复合物附着于靶细胞,从而对靶细胞产生应答。如果靶细胞是患病,异物或恶性细胞,则此方法可能用于促进免疫细胞中T细胞对靶细胞的裂解系统。如果靶细胞是抗原呈递细胞,则可以使用此方法促进特定T细胞克隆的增殖。本发明是预防和治疗恶性疾病的潜在用途,包括癌症和白血病,传染病,包括病毒感染等感染艾滋病毒,包括肺结核在内的细菌感染和寄生虫感染包括疟疾。

著录项

  • 公开/公告号CA2332642C

    专利类型

  • 公开/公告日2010-01-05

    原文格式PDF

  • 申请/专利权人 ALEXIS BIOTECH LIMITED;

    申请/专利号CA19992332642

  • 发明设计人 SAVAGE PHILIP MICHAEL;

    申请日1999-06-04

  • 分类号C07K19;A61K39/385;A61K47/48;C07K14/16;C07K14/74;A61K38;

  • 国家 CA

  • 入库时间 2022-08-21 18:42:53

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号